Shandong Weigao Group Medical Polymer Company Limited Dividend Bilgileri
Shandong Weigao Group Medical Polymer Company Limited hisse başına yıllık % {var1} temettüye sahiptir ve % {var2} oranında bir getiri sunmaktadır. Temettü altı ayda bir ödenmektedir ve son temettü hariç tarihi Oct 21, 2025 tarihindedir.
Dividend Yield
Yıllık Dividende
Özsermaye Tarihi
0.00%
$0.03
Oct 21, 2025
Ödeme Sıklığı
Ödeme Oranı
Altı ayda bir
0.00%
Dividend History
Özsermaye Tarihi
Nakit Tutarı
Kayıt Tarihi
Ödeme Tarihi
Oct 21, 2025
$0.1061
Oct 22, 2025
Nov 21, 2025
Oct 20, 2025
$0.0969
Oct 21, 2025
Nov 21, 2025
Jun 2, 2025
$0.1344
Jun 3, 2025
Jul 11, 2025
Oct 18, 2024
$0.1009
Oct 21, 2024
Nov 22, 2024
Jun 3, 2024
$0.1035
Jun 4, 2024
Jul 12, 2024
Oct 19, 2023
$0.08
Oct 20, 2023
Nov 24, 2023
Dividend Grafikleri
SHWGF Kâr Payları
SHWGF Dividend Growth (Yıllık Üstünlük)
Follow-Up Questions
Shandong Weigao Group Medical Polymer Company Limited'in şu anki temettü ödemesi ve yıllık temettüsü nedir?
Shandong Weigao Group Medical Polymer Company Limited'in temettü ödeme oranı nedir?
SHWGF'ün temettü dağıtım tarihi nedir?
Shandong Weigao Group Medical Polymer Company Limited ne sıklıkla temettü öder?
Önemli İstatistikler
Önceki Kapanış
$0.69
Açılış fiyatı
$0.6899
Günün Aralığı
$0.6899 - $0.69
52 haftalık aralık
$0.66 - $0.76
İşlem hacmi
468
Ort.Hacim
0
EPS (TTM)
0.06
Dividend yield
--
Piyasa Değeri
$3.0B
SHANDONG WEIGAO GROUP MEDICAL nedir?
Shandong Weigao Group Medical Polymer Co. Ltd. engages in the research and development, production, and sale of single-use medical device products and operates finance lease and factoring. The company is headquartered in Weihai, Shandong and currently employs 13,063 full-time employees. The company went IPO on 2004-02-27. The firm operates its businesses through six segments. The Medical Device segment produces and sells clinical care, medical testing, anesthesia and surgical related products and other consumables. The Orthopaedic Products segment produces and sells orthopaedic products, including tissue repair product line. The Interventional Products segment produces and sells tumour and blood vessel interventional instruments. The Pharma Packaging Products segment produces and sells pre-filled syringes and flushing syringes. The Blood Management Products segment produces and sells blood collection, irradiation, storage, separation and sterilization products. The Others segment engages in finance lease and factoring business. The firm mainly operates its businesses in the domestic and overseas markets.